Literature DB >> 20976837

Quality of life after surgery of the alimentary tract.

Marco Scarpa1.   

Abstract

In recent decades, patient-reported outcomes have become important in clinical medicine. Nowadays, health-related quality of life (HRQOL) is considered a primary outcome in many clinical trials, and it is often the major criterion for judging treatment success. At the beginning of the 21st century, morbidity and mortality rates after surgery of the alimentary tract have dropped dramatically and they can no longer be considered the only outcome measures to determine the success of a surgical procedure. QOL can yield a definitely more patient-orientated measure of outcome that provides us with a more formal measure of the patient's judgment and desires, which can influence treatment decisions. Nevertheless, despite a very large number of published papers on HRQOL, there is some skepticism on the value of HRQOL and other patient-related outcomes. Therefore, this topic highlight aims to assess how QOL after surgery of the alimentary tract is covered in the medical literature. Different reviews have analyzed the topic according to different points of view: benign and malignant disease; curative and palliative treatment; open and minimally invasive surgical approach; traditional and newly introduced surgical procedures. This topic highlight does not aim to cover all the possible diseases or different surgical procedures, but it does describe the different approaches in order to give the reader a broad spectrum of analysis of QOL after surgery. This quick overview could stimulate the reader to form his/her own opinion about how to use this primary outcome measure.

Entities:  

Mesh:

Year:  2010        PMID: 20976837      PMCID: PMC2965277          DOI: 10.3748/wjg.v16.i40.5020

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  16 in total

Review 1.  Health-related quality of life (HR-QOL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approval.

Authors:  G Apolone; G De Carli; M Brunetti; S Garattini
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  The two cultures of medicine: objective facts versus subjectivity and values.

Authors:  H Wulff
Journal:  J R Soc Med       Date:  1999-11       Impact factor: 5.344

3.  Health-related quality of life after restorative proctocolectomy for ulcerative colitis: long-term results.

Authors:  Marco Scarpa; Imerio Angriman; Cesare Ruffolo; Antonio Ferronato; Lino Polese; Michela Barollo; Alessandro Martin; Giacomo C Sturniolo; Davide F D'Amico
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

Review 4.  Coping theory and research: past, present, and future.

Authors:  R S Lazarus
Journal:  Psychosom Med       Date:  1993 May-Jun       Impact factor: 4.312

5.  Lottery winners and accident victims: is happiness relative?

Authors:  P Brickman; D Coates; R Janoff-Bulman
Journal:  J Pers Soc Psychol       Date:  1978-08

6.  Health related quality of life after surgery for colonic diverticular disease.

Authors:  Imerio Angriman; Marco Scarpa; Cesare Ruffolo
Journal:  World J Gastroenterol       Date:  2010-08-28       Impact factor: 5.742

7.  Symptom reporting in cancer patients II: relations to social desirability, negative affect, and self-reported health behaviors.

Authors:  M Koller; K Heitmann; J Kussmann; W Lorenz
Journal:  Cancer       Date:  1999-10-15       Impact factor: 6.860

Review 8.  The cancer patient and quality of life.

Authors:  Andrew Bottomley
Journal:  Oncologist       Date:  2002

9.  Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.

Authors:  Catherine Acquadro; Rick Berzon; Dominique Dubois; Nancy Kline Leidy; Patrick Marquis; Dennis Revicki; Margaret Rothman
Journal:  Value Health       Date:  2003 Sep-Oct       Impact factor: 5.725

Review 10.  Quality of life: a deconstruction for clinicians.

Authors:  Michael Koller; Wilfried Lorenz
Journal:  J R Soc Med       Date:  2002-10       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.